FFAR1; FFAR4; HTR7; ADRA1A; HTR2A; DRD4; DRD1; DRD2; HTR1A; | |
TSHR; NPSR1; CXCR1; | |
TDP1; PLA2G1B; BLM; FAAH; RECQL; TERT; PIK3R1; GLO1; HPGD; MPO; AKR1B1; HSD17B2; HSD17B10; ALOX15; ALOX12; NOX4; PYGL; POLB; | |
AKT1; MET; CAMK2B; CSNK2A1; DAPK1; AXL; FLT3; NEK6; PKN1; NEK2; SRC; IGF1R; PTK2; AURKB; GSK3B; CDK1; PIM1; NUAK1; ALK; KDR; | |
CA12; CA5B; CA3; CA14; CA7; CA5A; CA4; CA6; CA2; CA9; CA1; | |
THRB; | |
PPARA; PPARG; PPARD; | |
ESR1; ESR2; | |
KDM4E; | |
MAOA; ALOX5; XDH; | |
MMP13; MMP3; MMP2; MMP9; | |
ELANE; | |
BACE1; | |
STAT6; HIF1A; NFKB1; TP53; | |
CREBBP; | |
ABCC1; ABCG2; | |
LMNA; FABP5; MAPT; FABP3; F3; HTT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Aspartic protease | BACE1 | Beta-secretase 1 | P56817 | CHEMBL4822 |
ATP-binding cassette | ABCC1 | Multidrug resistance-associated protein 1 | P33527 | CHEMBL3004 |
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Bromodomain | CREBBP | CREB-binding protein | Q92793 | CHEMBL5747 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 3.211E-12 | 1.110E-09 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.908E-11 | 5.541E-09 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 7.928E-10 | 1.439E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C8, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.458E-09 | 3.965E-07 | CYP1A2, CYP2C19, CYP2C8, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 2.458E-09 | 3.965E-07 | CYP1A2, CYP2C8, CYP2C9, CYP2D6, CYP3A4 |
BP | Unclassified; | GO:2000021; regulation of ion homeostasis | 1.143E-07 | 1.290E-05 | CA2, CA7, DRD1, DRD2, HTR2A, HTT, KDR, NPSR1, PLA2G1B, SRC |
BP | Unclassified; | GO:0032846; positive regulation of homeostatic process | 2.474E-07 | 2.482E-05 | AURKB, CA2, CA7, DRD1, DRD2, HIF1A, HTT, NEK2, NPSR1, PLA2G1B |
BP | GO:0008152; metabolic process | GO:0006691; leukotriene metabolic process | 4.882E-07 | 4.543E-05 | ABCC1, ALOX12, ALOX15, ALOX5, PLA2G1B |
BP | Unclassified; | GO:0032844; regulation of homeostatic process | 9.220E-07 | 8.194E-05 | AURKB, CA2, CA7, DRD1, DRD2, HIF1A, HTR2A, HTT, KDR, NEK2, NPSR1, PLA2G1B, SRC |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 1.061E-06 | 9.241E-05 | AKT1, HIF1A, LMNA, PPARD, SRC, TERT, TP53 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 4.149E-07 | 4.927E-06 | CYP1A2; HSD17B2; CYP1A1; CYP1B1; CYP3A4; CYP19A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.402E-04 | 7.736E-04 | CYP1A2; XDH |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 4.502E-05 | 1.989E-04 | MAOA; CYP1A2; CYP1A1; CYP1B1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.312E-08 | 5.491E-07 | CYP2C9; CYP2C8; PLA2G1B; ALOX5; ALOX15; ALOX12; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 8.381E-11 | 3.432E-09 | CYP2C9; CYP2C8; PLA2G1B; CYP1A2; ALOX15; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 1.752E-05 | 9.512E-05 | CYP2C9; CYP2C8; CYP1A2; CYP1A1; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.976E-22 | 5.654E-20 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA4; CA7; CA6; CA9; CA14 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.644E-06 | 1.487E-05 | CYP2C9; CYP2D6; CYP1A2; CYP1A1; CYP1B1; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.931E-08 | 1.041E-06 | CYP2C9; CYP2C8; MAOA; CYP2D6; CYP1A2; CYP3A4; CYP2C19 |
hsa00983 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.180E-02 | 3.944E-02 | CYP3A4; XDH |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Trematode infection | B66.9 | ESR1 |
A00-B99: Certain infectious and parasitic diseases | Visceral leishmaniasis | B55.0 | PLA2G1B |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | Leishmaniasis | B55.0 | PLA2G1B |
A00-B99: Certain infectious and parasitic diseases | Human immunodeficiency virus infection | B20-B26 | FLT3 |
A00-B99: Certain infectious and parasitic diseases | Septic shock | A41.9 | ELANE |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9; DRD2 |
A00-B99: Certain infectious and parasitic diseases | Lymphatic filariasis | B74 | ALOX5 |
A00-B99: Certain infectious and parasitic diseases | HCV infection | B17.1, B18.2 | MMP3 |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |